- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.01. | WORK Medical Technology Group LTD - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 30.12.25 | Work Medical Technology Group schließt Aktienzusammenlegung im Verhältnis 100:1 ab | 5 | Investing.com Deutsch | ||
| 30.12.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| 29.12.25 | WORK Medical Shares Jump 9% On Exclusive AI Blood Analysis Deal In China | 1 | RTTNews | ||
| 29.12.25 | WORK Medical Signs East China Distribution Deal For AI Blood Analyzer, Stock Up | 1 | RTTNews | ||
| 29.12.25 | Produktionszulassung für KI-Blutanalysegerät beflügelt Aktie von WORK Medical | 2 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical subsidiary signs exclusive distribution deal for blood analyzer | 1 | Investing.com | ||
| 29.12.25 | WORK Medical schließt exklusiven Vertriebsvertrag für KI-Blutanalysegerät in Ostchina | - | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 360 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 29.12.25 | HANGZHOU - WORK Medical subsidiary receives AI blood analyzer approval | 1 | Investing.com | ||
| 29.12.25 | WORK Medical erhält Zulassung für KI-gestütztes Blutanalysegerät | 1 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer | 177 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.12.25 | WORK Medical führt Aktienzusammenlegung im Verhältnis 1:100 durch | 13 | Investing.com Deutsch | ||
| 24.12.25 | WORK Medical to implement 1-for-100 reverse stock split | 3 | Investing.com | ||
| 24.12.25 | WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 | 652 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.11.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 10 | SEC Filings | ||
| 07.11.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 04.11.25 | WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation | 1 | GlobeNewswire (USA) | ||
| 22.10.25 | Why Work Medical (WOK) Stock Jumped 50% After Hours? | 2 | Benzinga.com |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 4,029 | +0,09 % | Teladoc Health, Inc.: Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors | NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than... ► Artikel lesen | |
| HIMS & HERS HEALTH | 13,280 | +0,04 % | Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform | Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada.
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS)... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,280 | -4,37 % | Plus Therapeutics Inc.: Plus Therapeutics Provides Business Update on REYOBIQ Clinical Program and U.S. CNSide Commercialization | HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 22.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.01.2026ISIN NameCA74290F1009 PROBE... ► Artikel lesen | |
| VERU | 2,450 | -2,00 % | Veru Inc.: Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress | -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter- --Company to host conference call and webcast... ► Artikel lesen | |
| SENSEONICS | 6,900 | -0,72 % | Sequel, Senseonics announce full launch of Eversense 365 CGM, twiist pump pairing | ||
| ELEKTA | 5,185 | -1,61 % | Elekta AB: Elekta presents Strategic Update: growth, innovation, and operations | STOCKHOLM - Elekta (EKTA-B.ST) today, at 14:00 CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by... ► Artikel lesen | |
| IMUNON | 2,580 | +2,38 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 4,640 | -3,73 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results | SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments... ► Artikel lesen | |
| AXE COMPUTE | 1,950 | +2,09 % | Axe Compute Inc: Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute | PITTSBURGH, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Axe Compute (or the "Company") (Nasdaq: AGPU) today announced the appointment of Christopher Miglino as Chief Executive Officer, marking a pivotal development... ► Artikel lesen | |
| AXOGEN | 30,000 | 0,00 % | Beyond The Numbers: 6 Analysts Discuss Axogen Stock | ||
| MEDLINE | 42,600 | +0,47 % | BioNTech- und Nvidia-Aktien verkauft, Medline und Alphabet rein: Erste 13F-Filings sind da! | Der britische Vermögensverwalter Baillie Gifford hat als einer der ersten sein 13F-Filing für das 4. Quartal abgegeben. Unter den großen Namen im Portfolio gibt es ein paar spannende Veränderungen.... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 4,520 | -5,04 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year | First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum... ► Artikel lesen | |
| TALKSPACE | 5,000 | +3,73 % | Talkspace Announces Fourth Quarter and Full Year 2025 Results | 4Q 2025 total revenue grew 29% year-over-year to $63.0 million4Q 2025 net income of $4.8 million and adjusted EBITDA1 of $6.6 million Full-year 2025 total revenue grew 22% year-over-year to $228.9... ► Artikel lesen | |
| VENUS CONCEPT | 1,627 | 0,00 % | Venus Concept Inc.: Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC | TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market... ► Artikel lesen |
WORK MEDICAL TECHNOLOGY GROUP LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,010 (-0,69 %) liegt der Kurs bei 1,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WORK MEDICAL TECHNOLOGY GROUP LTD finden Sie auf Wallstreet Online.